Yeruk Mulugeta

860 total citations
19 papers, 595 citations indexed

About

Yeruk Mulugeta is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Economics and Econometrics. According to data from OpenAlex, Yeruk Mulugeta has authored 19 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pediatrics, Perinatology and Child Health, 5 papers in Pharmacology and 5 papers in Economics and Econometrics. Recurrent topics in Yeruk Mulugeta's work include Pharmaceutical studies and practices (17 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pharmaceutical Economics and Policy (5 papers). Yeruk Mulugeta is often cited by papers focused on Pharmaceutical studies and practices (17 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pharmaceutical Economics and Policy (5 papers). Yeruk Mulugeta collaborates with scholars based in United States, Netherlands and Switzerland. Yeruk Mulugeta's co-authors include Gilbert J. Burckart, Ping Zhao, Kevin Krudys, GJ Burckart, Rupert W. Leong, S-M Huang, Susan McCune, Lynne Yao, Hari Cheryl Sachs and Dionna J. Green and has published in prestigious journals such as The Journal of Pediatrics, Clinical Pharmacology & Therapeutics and British Journal of Clinical Pharmacology.

In The Last Decade

Yeruk Mulugeta

19 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yeruk Mulugeta United States 11 369 126 122 74 58 19 595
Benjamin Staley United States 9 161 0.4× 227 1.8× 39 0.3× 55 0.7× 35 0.6× 15 635
Farzaneh Salem United Kingdom 9 196 0.5× 119 0.9× 90 0.7× 10 0.1× 18 0.3× 21 377
Hélène Théophile France 15 93 0.3× 49 0.4× 171 1.4× 39 0.5× 16 0.3× 28 602
Ana Alvarez-Requejo Spain 8 130 0.4× 79 0.6× 90 0.7× 76 1.0× 20 0.3× 13 576
Felix Stader Switzerland 14 123 0.3× 111 0.9× 57 0.5× 20 0.3× 28 0.5× 39 455
Robin Michelet Germany 13 111 0.3× 98 0.8× 187 1.5× 19 0.3× 30 0.5× 65 703
Elisa A. M. Calvier Netherlands 10 173 0.5× 83 0.7× 92 0.8× 8 0.1× 31 0.5× 17 308
Jill Fiedler‐Kelly United States 13 101 0.3× 51 0.4× 161 1.3× 13 0.2× 54 0.9× 47 653
Rubin Lubomirov Spain 13 128 0.3× 162 1.3× 47 0.4× 18 0.2× 14 0.2× 38 717
Kathleen M. Tornatore United States 18 218 0.6× 84 0.7× 61 0.5× 17 0.2× 8 0.1× 43 818

Countries citing papers authored by Yeruk Mulugeta

Since Specialization
Citations

This map shows the geographic impact of Yeruk Mulugeta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeruk Mulugeta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeruk Mulugeta more than expected).

Fields of papers citing papers by Yeruk Mulugeta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yeruk Mulugeta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeruk Mulugeta. The network helps show where Yeruk Mulugeta may publish in the future.

Co-authorship network of co-authors of Yeruk Mulugeta

This figure shows the co-authorship network connecting the top 25 collaborators of Yeruk Mulugeta. A scholar is included among the top collaborators of Yeruk Mulugeta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yeruk Mulugeta. Yeruk Mulugeta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tuchman, Shamir, Yeruk Mulugeta, George J. Schwartz, et al.. (2025). The Advancing the Development of Pediatric Therapeutics 8 (ADEPT 8) Workshop on Drug Dosing in Pediatric Patients with Renal Impairment. The Journal of Pediatrics. 283. 114624–114624. 1 indexed citations
2.
Robins, Cynthia S., Paula Darby Lipman, Tamara Johnson, et al.. (2024). Healthcare providers’ use of a concise summary to prescribe for lactating patients. Research in Social and Administrative Pharmacy. 20(5). 531–538. 1 indexed citations
3.
Fleming, Thomas R., Christine Garnett, Laurie S. Conklin, et al.. (2022). Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation. Therapeutic Innovation & Regulatory Science. 57(1). 109–120. 10 indexed citations
4.
Bhatt‐Mehta, Varsha, Haihao Sun, Yeruk Mulugeta, et al.. (2022). Pediatric Efficacy Extrapolation in Drug Development Submitted to the US Food and Drug Administration 2015–2020. The Journal of Clinical Pharmacology. 63(3). 307–313. 12 indexed citations
5.
Momper, Jeremiah D., Kevin Krudys, Donna Griebel, et al.. (2020). Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy‐Induced Nausea and Vomiting. The Journal of Clinical Pharmacology. 60(6). 775–784. 4 indexed citations
6.
Barrett, Jeffrey S., Christina Bucci‐Rechtweg, S. Y. Amy Cheung, et al.. (2020). Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop. Clinical Pharmacology & Therapeutics. 108(1). 29–39. 9 indexed citations
7.
Anker, John N. van den, Susan McCune, Pieter Annaert, et al.. (2020). Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs. Pharmaceutics. 12(7). 685–685. 79 indexed citations
8.
Mulugeta, Yeruk, et al.. (2018). Paediatric extrapolation: A necessary paradigm shift. British Journal of Clinical Pharmacology. 85(4). 675–679. 26 indexed citations
9.
Mulugeta, Yeruk, Anne Zajicek, Jeff Barrett, et al.. (2017). Development of Drug Therapies for Newborns and Children. Pediatric Clinics of North America. 64(6). 1185–1196. 21 indexed citations
10.
McCune, Susan, Yeruk Mulugeta, & Gerri Baer. (2017). Collaboration in Regulatory Science to Facilitate Therapeutic Development for Neonates. Current Pharmaceutical Design. 23(38). 5801–5804. 1 indexed citations
11.
Zimmerman, Kanecia O., Christoph P. Hornik, P. Brian Smith, et al.. (2016). Exposure Matching of Pediatric Anti-infective Drugs: Review of Drugs Submitted to the Food and Drug Administration for Pediatric Approval. Clinical Therapeutics. 38(9). 1995–2005. 5 indexed citations
12.
Mehrotra, Nitin, Atul Bhattaram, Justin Earp, et al.. (2016). Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling. Drug Metabolism and Disposition. 44(7). 924–933. 58 indexed citations
13.
Mulugeta, Yeruk, Jeffrey S. Barrett, Robert M. Nelson, et al.. (2016). Exposure Matching for Extrapolation of Efficacy in Pediatric Drug Development. The Journal of Clinical Pharmacology. 56(11). 1326–1334. 62 indexed citations
14.
Mulugeta, Yeruk, et al.. (2015). Failed Pediatric Drug Development Trials. Clinical Pharmacology & Therapeutics. 98(3). 245–251. 67 indexed citations
15.
Momper, Jeremiah D., Dionna J. Green, Mark Hirsch, et al.. (2014). Drug development for pediatric neurogenic bladder dysfunction: Dosing, endpoints, and study design. The Journal of Clinical Pharmacology. 54(11). 1239–1246. 4 indexed citations
16.
McCune, Susan & Yeruk Mulugeta. (2014). Regulatory Science Needs for Neonates: A Call for Neonatal Community Collaboration and Innovation. Frontiers in Pediatrics. 2. 135–135. 15 indexed citations
17.
Momper, Jeremiah D., Yeruk Mulugeta, Dionna J. Green, et al.. (2013). Adolescent Dosing and Labeling Since the Food and Drug Administration Amendments Act of 2007. JAMA Pediatrics. 167(10). 926–926. 68 indexed citations
18.
Leong, Rupert W., et al.. (2012). Regulatory Experience With Physiologically Based Pharmacokinetic Modeling for Pediatric Drug Trials. Clinical Pharmacology & Therapeutics. 91(5). 926–931. 147 indexed citations
19.
Burckart, Gilbert J., Rupert W. Leong, Yeruk Mulugeta, et al.. (2012). Methodological Issues in the Design of Paediatric Pharmacokinetic Studies. Pharmaceutical Medicine. 26(1). 13–22. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Staley Breakdown of academic impact, for papers by Farzaneh Salem Breakdown of academic impact, for papers by Hélène Théophile Breakdown of academic impact, for papers by Ana Alvarez-Requejo Breakdown of academic impact, for papers by Felix Stader Breakdown of academic impact, for papers by Robin Michelet Breakdown of academic impact, for papers by Elisa A. M. Calvier Breakdown of academic impact, for papers by Jill Fiedler‐Kelly Breakdown of academic impact, for papers by Rubin Lubomirov Breakdown of academic impact, for papers by Kathleen M. Tornatore
Rankless by CCL
2026